We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Mobile Mini-Laboratory System Identifies SARS-CoV-2 Virus in 40 Minutes and Conducts 60 Tests per Day

By LabMedica International staff writers
Posted on 18 Nov 2020
Print article
Image: Mobile Mini-Laboratory System (Photo courtesy of Spindiag GmbH)
Image: Mobile Mini-Laboratory System (Photo courtesy of Spindiag GmbH)
A new mini-laboratory system can identify the SARS-CoV-2 virus within roughly 40 minutes and makes it possible to conduct up to 60 tests a day right on the spot where samples are taken.

Spindiag GmbH (Freiburg, Germany) is launching the coronavirus rapid test system that can identify the SARS-CoV-2 virus within roughly 40 minutes. To identify the coronavirus, Spindiag has redesigned a test principle of its own conception which has already worked for antibiotic-resistant bugs. At the heart of this mobile mini-laboratory is a roughly one centimeter thick, crescent-shaped cartridge, with an integrated swab. Nurses and caregivers can use it to take smear tests, for instance from a patient’s nose or throat. They can then push the swab back into the cartridge and place it in an analytical instrument that automatically analyzes the swab and displays the test result. This makes it possible to conduct up to 60 tests a day with a mini-laboratory right on the spot where the samples are taken.

Spindiag’s test process is polymerase chain reaction (PCR)-based. Using PCR, the virus’ genome is replicated sufficiently to be identified even if there are only small quantities in a sample. Spindiag will first introduce its new coronavirus rapid test in Germany and then in all other European Union countries.

Related Links:
Spindiag GmbH

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.